The Plasma Levels of 3-Hydroxybutyrate, Dityrosine, and Other Markers of Oxidative Stress and Energy Metabolism in Major Depressive Disorder

Major depressive disorder (MDD) is a serious mental disease with a pathophysiology that is not yet fully clarified. An increasing number of studies show an association of MDD with energy metabolism alteration and the presence of oxidative stress. We aimed to evaluate plasma levels of 3-hydroxybutyra...

Full description

Bibliographic Details
Main Authors: Michaela Krivosova, Eduard Gondas, Radovan Murin, Matus Dohal, Igor Ondrejka, Ingrid Tonhajzerova, Peter Hutka, Nikola Ferencova, Zuzana Visnovcova, Igor Hrtanek, Juraj Mokry
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/4/813
Description
Summary:Major depressive disorder (MDD) is a serious mental disease with a pathophysiology that is not yet fully clarified. An increasing number of studies show an association of MDD with energy metabolism alteration and the presence of oxidative stress. We aimed to evaluate plasma levels of 3-hydroxybutyrate (3HB), NADH, myeloperoxidase, and dityrosine (di-Tyr) in adolescent and adult patients with MDD, compare them with healthy age-matched controls, and assess the effect of antidepressant treatment during hospitalisation on these levels. In our study, plasmatic levels of 3HB were elevated in both adolescents (by 55%; <i>p</i> = 0.0004) and adults (by 88%; <i>p</i> < 0.0001) with MDD compared to controls. Levels of dityrosine were increased in MDD adults (by 19%; <i>p</i> = 0.0092) but not adolescents. We have not found any significant effect of antidepressants on the selected parameters during the short observation period. Our study supports the findings suggesting altered energy metabolism in MDD and demonstrates its presence independently of the age of the patients.
ISSN:2075-4418